Abingdon Health (LON:ABDX) Reaches New 52-Week High – Here’s Why

Abingdon Health Plc (LON:ABDX)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 13 and last traded at GBX 12.30, with a volume of 611741 shares traded. The stock had previously closed at GBX 12.50.

Abingdon Health Price Performance

The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96. The stock’s fifty day simple moving average is GBX 8.62 and its 200-day simple moving average is GBX 7.27. The company has a market capitalization of £30.88 million, a P/E ratio of -15.19 and a beta of 0.12.

Abingdon Health (LON:ABDX) last released its quarterly earnings results on Tuesday, March 17th. The company reported GBX (0.43) earnings per share (EPS) for the quarter. Abingdon Health had a negative net margin of 33.88% and a negative return on equity of 55.91%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.